10/31/2019 10:02 AM
Near the top of the Nasdaq this morning sit two drug stocks. First up is Dicerna Pharmaceuticals Inc (NASDAQ:DRNA), after the company scored a research and licensing agreement with Roche AG. The two ...
10/29/2018 9:53 AM
The shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) are trading near the top of the Nasdaq today, up 16.5% at $15.14. The gene-silencing expert just announced a licensing deal with Eli Lilly (LLY...